Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2022-05-21 Major Shareholding Noti…
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Major Shareholding Notification Classification · 100% confidence The document is a formal notification addressed to the BSE Limited regarding the acquisition of shares by ICICI Prudential Mutual Fund in Lupin Limited. It references the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and provides detailed shareholding percentages before and after the acquisition. The content focuses on disclosure of substantial shareholding crossing the 5% threshold, which is a regulatory requirement for notifying significant changes in share ownership. There is no indication of financial statements, earnings data, management discussion, or other report types. The document is a notification of a major shareholding change as per regulatory requirements.
2022-05-21 English
Audio/Video recording of the Investor Presentation FY 2021-22.
Investor Presentation Classification · 95% confidence The document is a short communication dated May 19, 2022, addressed to stock exchanges, informing about the hosting of an audio/video recording of the Investor Presentation for FY 2021-22 on the company's website. It references a regulatory requirement (SEBI Listing Obligations) and provides a web link to the recording. The document does not contain the presentation itself, financial data, or detailed analysis, but merely announces the availability of the investor presentation recording. The document length is only 1519 characters, which is short and consistent with an announcement rather than the full presentation. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Investor Presentation (IP).
2022-05-19 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the hosting of an audio/video recording of the Investor Presentation for FY 2021-22 on the company's website. It references a regulatory requirement (SEBI Listing Obligations) and provides a link to the recording. The document is short (1513 characters) and does not contain the presentation itself, financial data, or detailed analysis. It is an announcement about the availability of the investor presentation, not the presentation document itself. Therefore, it fits the category of Investor Presentation (IP) as it relates to investor presentations, but since it is only an announcement of the recording's availability, it is best classified as Regulatory Filings (RNS) under the fallback rule for announcements that do not contain the actual report or presentation content.
2022-05-19 English
Investor Presentation FY 2021-22.
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation FY 2021-22' and is addressed to stock exchanges pursuant to SEBI regulations. It contains detailed strategic vision, market analysis, quarterly sales data, P&L highlights, and other operational and financial information. The content is typical of an investor presentation aimed at providing investors with insights into company performance, strategy, and outlook. There is no indication that this is a full annual report, audit report, or earnings release. The document is not a brief announcement or a certification but a detailed presentation. Therefore, the most appropriate classification is 'Investor Presentation' (IP). The document length and detail support a high confidence score.
2022-05-19 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation FY 2021-22' and is addressed to stock exchanges pursuant to SEBI regulations, indicating it is a formal investor communication. The content includes strategic vision, industry trends, quarterly sales snapshots, important developments, and detailed financial highlights for Q4 FY 2022. It contains forward-looking statements, market analysis, and operational updates typical of an investor presentation. The document is approximately 15,000 characters long and contains detailed presentation slides and financial data, not just an announcement or a brief summary. Therefore, it fits the definition of an Investor Presentation (IP).
2022-05-19 English
Lupin Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2022, inter alia, hasrecommended dividend @200% i.e.Rs. 4/- per equity share of ....
Annual Report Classification · 95% confidence The document is a detailed communication from Lupin Limited to stock exchanges and regulatory bodies, referencing compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It includes approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2022, along with auditors' reports. The document contains extensive financial data including revenue, expenses, profit/loss, and tax details for the specified periods. The presence of full financial statements and audit opinions indicates this is a comprehensive financial report rather than a brief announcement or certification. The document also mentions dividend recommendations subject to shareholder approval, which is typical in annual financial reporting. Given the fiscal year-end date and the comprehensive financial data, this document fits the definition of an Annual Report (10-K equivalent) rather than an interim or quarterly report, earnings release, or other filing types. Therefore, the appropriate classification is Annual Report (10-K).
2022-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.